Merckaccessportal-renflexis.com

Merckaccessportal-renflexis.com has Server used 107.154.75.185 IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2017-05-18 (5 years, 1 day) and hosted in Dover United States, server ping response time 153 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Merckaccessportal-renflexis keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

Notice! No data available for this site.

Hosting Provider

Website: Merckaccessportal-renflexis.com
Hostname: 107.154.75.185.ip.incapdns.net
Country:
NetName:
Address: 3400 Bridge Parkway, Suite 200,
Region: DE
City: Dover
Postal Code: 19901
Latitude: 39.158798217773
Longitude: -75.494102478027
Area Code: 302
Email Abuse1. [email protected]
2. [email protected]
3. [email protected]
4. [email protected]
5. [email protected]
6. [email protected]
7. [email protected]
8. [email protected]
9. [email protected]
10. [email protected]
11. [email protected]

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Revo.com (53 min ago)

   » Bobbyjonesband.com (11 hours ago)

   » Huishoubao.com (4 day ago)

   » M1file.com (5 day ago)

   » Renhomesantalya.com (2 day ago)

   » Napadrivertours.com (1 day ago)

Results For Websites Listing

Found 8 Websites with content related to this domain, It is result after search with search engine

Merckaccessportal.com   DA: 21 PA: 7 MOZ Rank: 28

  • Resources available for health care providers
  • To enroll patients into The Merck Access Program, please visit www.merckaccessprogram-keytruda.com
  • For additional information about The Merck Access Portal, please call 855-257-3932

Merck.com   DA: 13 PA: 50 MOZ Rank: 64

  • Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the U.S
  • launch of RENFLEXIS™ (infliximab-abda), a biosimilar of the originator biologic medicine Remicade (infliximab)
  • RENFLEXIS was approved by the U.S
  • Food and Drug Administration (FDA) on April 21 for all eligible indications
  • RENFLEXIS is the first medicine …

Merckaccessprogram.com   DA: 26 PA: 26 MOZ Rank: 54

  • The Merck Access Program may be able to help answerquestions about access and support, including: Benefit investigations, the prior authorization and appeals process
  • Insurance coverage for patients
  • Co-pay assistance for eligible patients
  • Referral to the Merck Patient Assistance Program for eligibility
  • determination (provided through the

Renflexis.com   DA: 17 PA: 17 MOZ Rank: 37

  • To speak with a representative from The Organon Access Program, call 866-847-3539 Monday to Friday, 8 AM to 8 PM Eastern Time
  • Find out about insurance coverage for RENFLEXIS, including any out-of-pocket costs to you
  • Learn about options for co-pay assistance for eligible, privately-insured patients.

Organonaccessprogram-renflexis.com   DA: 38 PA: 38 MOZ Rank: 80

  • Before prescribing RENFLEXIS, please read the accompanying Prescribing Information, including the Boxed Warning about serious infections and malignancies
  • The Medication Guide also is available
  • THE ORGANON ACCESS PROGRAM FOR RENFLEXIS.

Merckaccessprogram.com   DA: 26 PA: 5 MOZ Rank: 36

  • The Merck Access Program (MAP) may be able to help answer questions about: Insurance coverage
  • Co-pay assistance for eligible patients
  • Referral to the Merck Patient Assistance Program for eligibility determination

Merckaccessprogram-keytruda.com   DA: 35 PA: 40 MOZ Rank: 81

  • The Merck Co-pay Assistance Program offers assistance to eligible, privately insured patients who need help affording the out-of-pocket costs for KEYTRUDA
  • Once enrolled, eligible, privately insured patients pay the first $25 of their co-pay per infusion
  • Maximum co-pay assistance program benefit is $25,000 per patient, per calendar year.

Recently Analyzed Sites

Revo.com (53 min ago)

Bobbyjonesband.com (11 hours ago)

Huishoubao.com (4 day ago)

M1file.com (5 day ago)

Trekksoft.com (7 day ago)

Tibbo.com (4 day ago)

Johnfasanomd.com (16 seconds ago)

Tailspinbandsc.com (4 day ago)

Dungscanada.com (10 day ago)

Jfsorange.org (4 day ago)

Marloweslu.com (53 min ago)